TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Cannabis Stocks
Better Cannabis Buy: Canopy Growth Stock or Tilray?
Investing
2 TSX Stocks to Buy in 2023 — and 1 to Avoid!
Investing
3 TSX Stocks Most Likely to Double in 2023
Cannabis Stocks
Are Cannabis Stocks Still a Thing in 2023?
Cannabis Stocks
Why Canopy Growth Stock Fell 72% Last Year
Cannabis Stocks
The Single Best Pot Stock to Buy in December 2022
Cannabis Stocks
The Investment Window Is Closing on 3 Big-Name Cannabis Stocks
Cannabis Stocks
Cannabis Stocks – Should Investors Buy Before 2023?
Cannabis Stocks
Is Canopy Growth Stock a Buy in December 2022?
Cannabis Stocks
U.S. Legalization Won’t Save Cannabis Stocks
Cannabis Stocks
5 Things to Know About Cannabis Stocks Before 2023